In cases of familial primary ovarian insufficiency and disorders of gonadal development, consider NR5A1/SF-1 sequence variants.


Journal

Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 11 04 2019
revised: 24 09 2019
accepted: 02 10 2019
pubmed: 14 12 2019
medline: 10 4 2021
entrez: 14 12 2019
Statut: ppublish

Résumé

Primary ovarian insufficiency (POI) is defined as the early exhaustion of ovarian function, before the age of 40 years. Its origin is genetic in 20-25% of cases. In rare cases, sequence variants of the NR5A1/SF-1 gene may result in POI, or in various disorders of gonadal development (DGD) or adrenal insufficiency. This study describes the cases of two families in which the association of DGD and POI enabled a diagnosis of NR5A1 deleterious variations. Their clinical, hormonal, ultrasound and genetic characteristics are reported. The mothers of the affected children were 21 and 29 years when POI was diagnosed. Each nonetheless had two spontaneous pregnancies. The children have different phenotypes and different forms of DGD. None of the affected family members had adrenal insufficiency. A new sequence variant of the NR5A1 gene was identified in one family: p.Cys283Phe (c.848G>T), and the NR5A1 sequence variant c.86G>C was found in the other family. Sequence variation of the NR5A1 gene is a possibility that must be considered when a woman with POI or a diminished ovarian reserve has a family member or child with DGD. If a variant is identified, genetic counselling is essential for the patient and his/her family.

Identifiants

pubmed: 31831369
pii: S1472-6483(19)30753-9
doi: 10.1016/j.rbmo.2019.10.002
pii:
doi:

Substances chimiques

Steroidogenic Factor 1 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

151-159

Informations de copyright

Copyright © 2019 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Auteurs

Juliette Bertrand-Delepine (J)

CH Calais, Department of Obstetrics and Gynecology, Calais F-62100, France.

Sylvie Manouvrier-Hanu (S)

Université de Lille. Lille, CHU Lille, Clinique de Génétique, EA 7364-RADEME, Lille F-59000, France.

Maryse Cartigny (M)

CHU Lille, Centre de Référence DEV-GEN, Lille F-59000, France.

Françoise Paris (F)

Département d'Endocrinologie et de Gynécologie Pédiatrique CHU Arnaud de Villeneuve, 34090 Montpellier, Département de Génétique, IURC, Equipe DEV-GEN, Montpellier 34090, France.

Delphine Mallet (D)

CHU Lyon, Laboratoire de Biochimie et Biologie Moléculaire Grand Est, UM Pathologies Endocriniennes Rénales Musculaires et Mucoviscidose - Centre de Référence DEV-GEN, Bron F-69677, France.

Pascal Philibert (P)

Département d'Endocrinologie et de Gynécologie Pédiatrique CHU Arnaud de Villeneuve, 34090 Montpellier, Département de Génétique, IURC, Equipe DEV-GEN, Montpellier 34090, France.

Yves Morel (Y)

CHU Lyon, Laboratoire de Biochimie et Biologie Moléculaire Grand Est, UM Pathologies Endocriniennes Rénales Musculaires et Mucoviscidose - Centre de Référence DEV-GEN, Bron F-69677, France; Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.

Christine Lefevre (C)

CHU Lille, Centre de Référence DEV-GEN, Lille F-59000, France.

Didier Dewailly (D)

Université de Lille, CHU Lille, INSERM U1172, Lille F-59000, France.

Sophie Catteau-Jonard (S)

Université de Lille, CHU Lille, INSERM U1172, Lille F-59000, France; Université de Lille, CHU Lille, Department of Reproductive Medicine, Lille F-59000, France. Electronic address: sophie.jonard@chru-lille.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH